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Background
Atherosclerosis is a chronic inflammatory disease of large- and medium-size arter-
ies [1]. Although the entire vasculature is exposed to the atherogenic effects of various 
Abstract 
Background: It is a known fact that blood flow pattern and more specifically the pul-
satile time variation of shear stress on the vascular wall play a key role in atherogenesis. 
The paper presents the conception, the building and the control of a new in vitro test 
bench that mimics the pulsatile flows behavior based on in vivo measurements.
Methods: An in vitro cardiovascular simulator is alimented with in vivo constraints 
upstream and provided with further post-processing analysis downstream in order to 
mimic the pulsatile in vivo blood flow quantities. This real-time controlled system is 
designed to perform real pulsatile in vivo blood flow signals to study endothelial cells’ 
behavior under near physiological environment. The system is based on an internal 
model controller and a proportional-integral controller that controls a linear motor 
with customized piston pump, two proportional-integral controllers that control the 
mean flow rate and temperature of the medium. This configuration enables to mimic 
any resulting blood flow rate patterns between 40 and 700 ml/min. In order to feed the 
system with reliable periodic flow quantities in vivo measurements were performed. 
Data from five patients (1 female, 4 males; ages 44–63) were filtered and post-pro-
cessed using the Newtonian Womersley’s solution. These resulting flow signals were 
compared with 2D axisymmetric, numerical simulation using a Carreau non-Newtonian 
model to validate the approximation of a Newtonian behavior.
Results: This in vitro test bench reproduces the measured flow rate time evolution 
and the complexity of in vivo hemodynamic signals within the accuracy of the relative 
error below 5%.
Conclusions: This post-processing method is compatible with any real complex 
in vivo signal and demonstrates the heterogeneity of pulsatile patterns in coronary 
arteries among of different patients. The comparison between analytical and numeri-
cal solution demonstrate the fair quality of the Newtonian Womersley’s approximation. 
Therefore, Womersley’s solution was used to calculate input flow rate for the in vitro 
test bench.
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systemic risk factors (e.g., dyslipidemia, smoking, hypertension, diabetes and genetic 
predisposition) [2–5], atherosclerotic lesions form at specific regions of the arterial tree. 
This behavior is associated with local variations in arterial hemodynamic properties and 
more particularly with the pulsatile time dependent evolution of the wall shear stress. 
The effects of shear stress are linked to the expression levels of atheroprotective and 
atherosensitizing endothelial genes [6, 7], cells need to be able to adapt to these con-
stantly changing stimuli.
Several studies [8–10] showed that vascular endothelial cells (ECs) respond differen-
tially to various patterns of pulsatile flow. Different EC responses can be recorded not 
only as a function of the time-averaged wall shear stress (WSS) but also of the wall shear 
stress time derivative (WSSTD), known also as the shear stress slew rate (SSSR) [8]. Also 
unsteady pulsatile flow induced quicker EC elongation and realignment rates as com-
pared to steady flow, despite identical time-averaged shear stress [8]. In their review [10], 
Lee Stoner et al. highlighted the two main limitations of in vitro studies in this field: (1) 
ECs from different tissue beds respond differently to a given flow; (2) most investigators 
submit ECs to a single type of stimulus (mostly a constant laminar shear stress), which 
probably fails to accurately mimic the complex response to the in vivo signals. Therefore, 
additional studies comparing different pulsatile flow patterns are required to enact the 
different conditions and the coronary wall shear stresses encountered in vivo.
In a review article dedicated to the shear stress biology of the endothelium, Davies 
et  al. [11] suggested future directions in this field of research. Two points caught our 
attention: (1) the design of in  vitro experiments that critically test the dominant fluid 
dynamic conditions existing in  vivo and address the validity of in  vitro models for 
intact tissues; (2) the determination of the importance of wall shear stress gradients on 
endothelial biology and of the temporal changes occurring throughout the cardiac cycle.
Based on these suggestions this manuscript focus on the signals related to real flow 
conditions as well as in the design of an in vitro device capable of reproducing hemo-
dynamic patterns of atherogenic conditions in vitro. To build this synthetic device, one 
needs to be able to mimic, in vitro, the exact signals encountered in the blood vessels. 
This ability would enable signals to be generated and applied to ECs or multisheet cul-
ture systems containing ECs and SMCs (smooth muscle cells) seeded in a transparent 
tube that would also allow observation under the microscope, recording of flow param-
eters and cell harvest after treatments. In order to development such device, the in vivo 
signal, such as blood velocity, have to be recorded and afterwards, post-processed to ena-
ble extraction of derived physical quantities, such as flow rate, WSS and WSSTD. With 
this goal (building an in vitro system that mimics real pulsatile blood patterns) in mind, 
the first objective was to accurately record real time dependent hemodynamic data. We 
performed in  vivo measurements using a Doppler flow ComboWire® (Volcano Corp.) 
in five patients, in order to gain knowledge of in vivo instantaneous maximal velocity of 
coronary arteries. In addition, the diameter of the artery at different points was meas-
ured by quantitative coronary angiography (QCA). Moreover, the hematocrit level from 
each patient was obtained. In order to extract additional derived physical variables, such 
as instantaneous flow rate, WSS and WSSTD from the in  vivo measurements, these 
quantities were post-processed. This applied post-process consisted in analytical inte-
gration of the unsteady Navier–Stokes equation using the Womersley’s relation based 
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on the assumption of a Newtonian fluid with constant viscosity in a straight rigid pipe. 
Since blood has a viscosity that varies with the shear rate [12], we used 2D axisymmetric, 
non-Newtonian CFD simulations (using a Carreau model) to validate the approximation 
of a Newtonian behavior.
Several projects are being carried out worldwide to provide a system capable mimick-
ing, outside the human body, the circulatory system [8, 13, 14]. However, these in vitro 
systems mostly focus on constant and simple harmonic flow oscillations. This can be an 
important limitation because in vivo studies have found [8, 14] that the flow topology 
and the consequent shear stress do have a significant role in vascular response. More-
over, some of these experiments hardly incorporate physiological properties in their 
experimental conditions such as sterility, gas balance, proper pH and osmolarity as well 
as duration of experiment.
Lately, several investigators have tried to improve the different types of systems in 
order to overcome these limitations [14–16]. Two of these attempts involve [14, 16] simi-
lar systems. Both aim to reproduce as accurately as possible the effective in vivo pressure 
signals. They also are closed, circular systems starting and ending in the same reservoir. 
The third one is based on the cone-plate model. They all have their advantages and dis-
advantages, the most important inconvenience being that they are mostly designed for 
one particular selected experiment. Thus one of them [16] was built to work with ECs in 
3D geometry (and involves straight pipes). The constructors focused mainly on pressure 
signal control. The second one [14] was built to allow researchers to work with different 
vessel geometries such as for example aneurysms and visualise different flows by using a 
PIV laser. In this case, researchers focused on simple flows. The corn-plate system [15] 
was designed to apply various shear stress signals on ECs attached to the plate. A 3D 
vessel model is also required to test medical devices such as Flow Diverted Stents. How-
ever, a pipe system requires large medium volumes which may create sterility problems. 
This problem was circumvented by the cone-plate system as a little mound of medium is 
used. Finally, none of these systems is fully automatic, they require manual adjustments, 
they have poor mobility and flexibility and they need an additional device to keep sterile 
conditions.
The system described here tries to preserve all advantages and overcome all disad-
vantages of the systems mentioned above. An additional key feature was to construct 
an universal machine capable reproducing, as accurately as possible, any in vivo flows 
measurements. Therefore, the research and development was focused on the control of 
pulsating flow rate and corresponding shear stress instead of pressure. Nevertheless, the 
system is designed so that in the future both pressure and flow rate would be controlled 
simultaneously. On top of mimicking the pulsatile flow behaviour and values recorded 
in vivo in the cardiovascular system, a supplementary constrain was to build a test bench 
easy to work with, mobile, as automatic and compact as possible and easily adaptable 
to work with additional supporting equipment such as PIV laser or CT scanner [17]. 
Downstream it should also automatically record values on demand such as flow rate, 
pressure, temperature and/or allow to capture images of the EC culture chamber while 
the system is running. All these requirements are met by the presented test bench.
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Methods
The study can be divided into three parts: (1) Measurements, including in vivo real time 
velocity; (2) post-processing measured data including filtering of the measured velocity 
and calculating derived quantities, such as flow rate, WSS and WSSTD, 3) reproduction 
of in vivo patient’s signal by presented developed in vitro test bench.
Patients: in vivo instantaneous velocity measurements and filtering
The patients were selected from those who needed a coronarography. The protocol num-
ber B3252006117 was approved by the Ethics Committee of OM008 of the ISPPC (Inter-
communale de Santé Publique du Pays de Charleroi) Hospital and the volunteers gave 
their written informed consent. Coronary arteries were selected devoid of any pathol-
ogy. The subjects included in the study are described in detail below:
Patient 1 was a 58-year-old male with stable angina admitted for elective percutane-
ous intervention (PCI) of a long and severe stenosis involving the third marginal branch. 
His past medical history included previous anterior myocardial infarction treated with a 
drug eluting stent (DES) on the left anterior descending artery (LAD), diabetes, hyper-
tension, active smoking and dyslipidemia. Access was obtained via the right radial artery 
using a 6 Fr XB 3.5 guide catheter. Angiographic images from the patient are shown in 
Fig. 1. After completion of the third marginal angioplasty, a ComboWire® was advanced 
into the proximal part of the LAD for coronary artery blood velocity measurements.
Patient 2 was a 44-year-old female undergoing coronary angiography for unstable 
angina. Her cardiac risk factors included dyslipidemia and active smoking. Access was 
obtained via the right femoral artery using a 6 Fr XB 3.5 guide catheter. After implanta-
tion of a bare metal stent (BMS) in the proximal LAD, a ComboWire® was advanced into 
the proximal part of the LAD.
Fig. 1 Angiographies showing the position of the wire for in vivo measurements. An angioplasty was per-
formed (pictures took for patient 1) in the left anterior descending artery (not shown). Access was obtained 
via the radial artery using a 6 Fr XB 3.5 guide catheter. It was then used to insert a ComboWire® allowing 
coronary blood velocity to be measured. Angiographies were taken from two different angles to visualize the 
position of the measurement point at a central position (right, zoom).
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Patient 3 was a 63-year-old man with stable angina pectoris and a positive myocar-
dial perfusion scan. His past medical history included insertion of a DES in the mid-
left anterior descending artery, hypertension and type 2 diabetes. Access was obtained 
via the right radial artery using a 5 Fr XB 3.5 guide catheter. The coronary angiogram 
showed no significant lesion on the coronary tree. The ComboWire® was placed in the 
intermediate artery for coronary blood velocity measurements.
Patient 4 was a 46-year-old man with dyslipidemia and previous implantation of BMSs 
in the proximal LAD and mid-left circumflex artery (LCX), who was undergoing control 
angiogram for recurrent angina. Access was obtained via the right radial artery using a 6 
Fr XB 3.5 guide catheter. After successful PCI of a LCX intra-stent occlusion, the combo 
wire was advanced in the intermediate artery for coronary blood velocity measurements.
Patient 5 was a 63-year-old man with stable angina pectoris and a positive myocar-
dial perfusion scan. His cardiac risk factors included dyslipidemia and type 2 diabetes. 
Access was obtained via the right radial artery using a 5 Fr XB 3.5 guide catheter. Coro-
nary angiogram showed no significant coronary lesion. The ComboWire® was placed in 
the LAD for coronary blood velocity measurements.
All patients had normal left ventricular systolic function except for patient 1 who had 
moderate left ventricular systolic dysfunction (ejection fraction of 45%).
For all the measurements, special care was taken to keep the tip of the wire in the 
center of the artery lumen and to obtain optimal measurements (Fig. 1) so that the meas-
ured velocity was maximal. The diameter of the artery at different points was measured 
by quantitative coronary angiography (QCA) and the values are shown in Table 1.
Measurements were made using a ComboMap® analysis unit (Volcano Corp.), a PC-
based system with an LCD color touch screen and a remote control operation. The 
ComboMap® system provides both pressure and flow rate (fractional flow reserve (FFR) 
and coronary flow reserve (CFR)) and allows digital storage to the hard drive or archi-
val storage to a CD. A Doppler flow intravascular wire (ComboWire® with a diameter 
0.3556 mm) was used to measure the instantaneous velocity.
The experimental data obtained by in vivo measurements in the coronary artery of all 
patients were recorded for further analysis. The resulting measured physiological data 
shows variations in the time period and velocity between each time cycle (Fig. 2). The 
variations indicate that the heartbeats are not constant and there are natural variations 
between cycles. Moreover, there are perturbations/artefacts in the measured data (not 
shown). Therefore, the measured data had to be processed in order to remove aberrant 
data and perturbations as well as to extract a representative signal for the measured 
Table 1 The averaged data decomposed by Fourier series and the variability of velocities 
as well as periods Δ and diameters D of the arteries for all patients tested
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Umin (cm/s) 3.7 ± 3.5 5.8 ± 1.5 5.8 ± 1.6 16.3 ± 3.6 9.6 ± 2.4
Umean (cm/s) 18.6 ± 4.1 22.7 ± 1.1 19.6 ± 3.2 35.7 ± 4.2 27.7 ± 5.9
Umax (cm/s) 32.9 ± 9.0 38.2 ± 2.3 33.2 ± 2.3 58.2 ± 10.9 41.1 ± 13.8
Period Δ (s) 1.06 ± 0.13 0.83 ± 0.06 0.81 ± 0.08 0.85 ± 0.08 0.81 ± 0.16
D (mm) 3.39 2.52 2.01 2.24 2.14
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velocity. The principle of the filtering strategy is presented in Fig. 2. Firstly, the in vivo 
data were processed to remove perturbed data probably caused by movements of the 
patient and/or the measurement sensors. The whole periodical signal was then cut into 
period signals, in the values, where minimum of a periodic velocity is, marked as circles 
(Fig. 2a). The cut periods were then filtered based on the following algorithm: The maxi-
mum, mean and minimum velocity, as well as the time period of specific cut periods 
should not vary more than 20% from the average respective value. However, the result-
ing physiological data still showed noticeable variability in the time period and the veloc-
ity between time cycles. This variability is illustrated in Table 1 and Fig. 2b. As shown 
for the first patient in Fig. 2b, the maximum velocity varied from 23.9 to 41.9 cm/s and 
the minimum velocity from 0.2 to 7.2 cm/s; the time period varied from 0.93 to 1.19 s. 
Therefore, to obtain a representative period, an average of all the filtered cycles was con-
structed, shown as the solid black line in Fig. 2b. The resulting average artery velocity 
signal was decomposed into a complex Fourier series for further analysis. We used 50 
harmonics to obtain good accuracy in the Fourier representation of velocity for each 
patient. The mean relative error was less than 0.5% for all cases and bellows the stand-
ard deviation resulting from the time variability of the measured signals. The minimum, 
maximum and average results for all patients are given in Table 1. Results of the Fou-
rier decomposition are shown in Fig. 3. The right panel (from top to bottom) illustrates 
the maximum filtered velocities. The velocity data varied from patient to patient both in 
intensity and curve shape. The Fourier series spectral analysis was also drawn in order to 
illustrate the filtering effect on the processed signals (Fig. 3, left-hand panel, from top to 
bottom). Results show that the filtering effects were different from patient to patient. In 
Fig. 2 Measured coronary velocity: raw data and post-processed data. A ComboWire® was used to measure 
coronary artery velocity signals. a A time window of the measurements of the coronary artery velocity 
signal measured in patient 1 indicating some variability from cycle to cycle. The cut points of the signal are 
indicated as empty circles. The differences between cut points present a period Δ of the heart beat. b Filtered 
coronary velocity cycles for patient 1. Gray lines represent superimposed filtered averaged velocity curves 
measured for all cycles in patient 1. The block line represents the mean filtered velocity signal. Variation in 
maximum velocity is indicated by the double-headed arrow. Umin ± δ, mean velocity; Umean ± δ, maximum 
velocity; Umax ± δ as well as period of the cycle Δ ± δ (arrows).
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patients 1 and 5, the spectral peaks were not altered by filtering. In contrast, the noise 
that appeared in patients 2, 3 and 4 required a strong filtering to obtain a representative 
signal. As a result, the number of representative cycles had to be reduced; therefore, for 
these patients, there is a shift between the spectral peaks.
Signal analysis and flow models
For the in vivo measurement part of this work, the critical question relates to the diver-
sity of in vivo velocity signals. Despite this variation, a method that allows us to deduce 
desired additional flow properties such as flow rate, wall shear rate, wall shear stress and 
Fig. 3 Calculated Fourier spectral analysis and filtered maximum velocities. The Fourier spectral analysis was 
performed in order to show the filtering effect on the processed signals (left-hand panel). In the left panel, the 
analyses are presented for the first 10 harmonics—black line: unfiltered signals, gray line: signal after filtering; 
circle: fundamental frequency of the heart cycle; the right-hand panel presents filtered maximum velocities for 
all examined patients. The five rows from top to bottom represent patients from 1 to 5.
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wall shear stress time derivative has to be found. Moreover, as mentioned, the main pur-
pose is to find the best method to quantify the flow properties from in vivo and in vitro 
measurements for further in vitro tests. The chosen method has to be accurate enough 
to reasonably describe properties of blood flows. Furthermore, it has to be fast enough 
in order to take as few computer resources as possible and easy to implement in any 
existing programming language such as C, Matlab® or Labview®.
For that purpose, the following elements had to be taken into account. First, as men-
tioned above, at the first stage, in  vitro experiments will be carried out on a straight, 
rigid and circular tube, seeded with endothelial cells. Moreover, the medium that will be 
used to fill the in vitro circuit is a Newtonian medium. The flow in most coronary arter-
ies excluding the heart, perturbations in the arteries such as stenosis and big arteries has 
a laminar character. These physical simplifications of the future in vitro model lead to 
many mathematical simplifications which allow to select the most widely used method 
in the blood calculations i.e. Womersley’s solution [18, 19]. This is the analytical solu-
tion obtained by integration of the unsteady Navier–Stokes equation in a circular vessel. 
Womersley’s solution is a valid solution for a Newtonian liquid with a constant viscosity. 
However, blood viscosity has non-Newtonian character. Therefore, a 2D axisymmetric, 
non-Newtonian CFD simulation was used to validate the assumption of an approximate 
Newtonian behavior of blood. Below, briefly, are presented equations that were used to 
calculate physical quantities and assess the validity of assumptions. For the analytical 
calculations a script in Matlab® program was written.
In order to check the validity of the first assumption—the laminar behavior of the 
fluid- the patient’s maximum mean velocity was taken into account in order to find the 
corresponding Reynolds number using as the reference value the pipe diameter and the 
mean velocity. A maximum Re number of 442 for patient 4 was found and it validated 
the assumption that the flow has a laminar behavior for the analyzed vessels.
The second assumption concerns the circularity of the vessel. In the first patient the 
coronary artery had a slightly elliptical section. The measured diameters of the coronary 
artery had an average size around 3.48 × 3.30 mm. This could correspond to reality or 
could be explained by limits in angiography resolution. In fact, we can assume that the 
section of the coronary artery has a circular geometry and that it will not have a sig-
nificant influence on the equation solution when the ratio between the small diameter 
(a) and the big one (b) is higher than 0.9 [19], Eq. 1. In our case, the ratio is 0.948, and 
therefore we took an approximate circular diameter of 3.387 mm based on the equation. 
Therefore a circular section was assumed for all patients. Diameters vary depending 
on patients between 3.387 mm for the first patient until 2.01 mm for the patient 3 (see 
Table 1).
where a and b are diameters of ellipse.
The third assumption consists in the approximation of a blood vessel as a rigid pipe. 
This will use in a first setting of our calculations as the in  vitro model will be a rigid 
tube. The systemic human arteries can be subdivided into two types—muscular and 
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tunica media as well as their size and the makeup of the internal and external elastic 
lamina. The larger arteries (>10 mm diameter) are generally elastic and the smaller ones 
(0.1–10 mm) tend to be muscular. For example large, muscular systemic arteries (e.g., 
femoral artery) increase in radius by about 10% [12, 20]. Moreover, the elasticity of blood 
vessels decreases with the size of vessel, age of people and/or due to an illness. In this 
study, diameters of the examined coronary arteries have dimensions 3.387 and 2.01 mm. 
According to the division presented above, it places them to the small muscular arteries 
for which change of the diameter is relatively small. Therefore, the assumed approxima-
tion of the vessel as a rigid pipe can be valid for these arteries.
The fourth assumption is about incompressibility of the liquid. In reality, like any other 
fluid, blood has a small compressibility that can be neglected, in particular when study-
ing the local aspect of the flow. Therefore we assumed an incompressible flow with den-
sity which depends on the level of hematocrit.
The last but not least assumption regards the non-Newtonian behavior of the blood. 
In normal conditions blood is a heterogeneous media principally made of about 55% of 
liquid plasma and of about 45% of red cells in suspension in the plasma. The concentra-
tion of red blood cells modifies the apparent viscosity of blood. Moreover, depending on 
the level of shear rate, that apparent viscosity changes and leads to the non-Newtonian 
behavior of blood, with viscosity decreasing as shear rate increases. However for our 
analytical estimation, we can assume that blood viscosity of a vessel whose diameter is 
larger than 1 mm is relatively constant, as the values of shear rate on the wall passes into 
a deformation region (above 100 s−1) where the viscosity is relatively constant. Therefore 
for the first calculations we used the average viscosity from Carreau model in the range 
of shear rate (0–1,000 s−1). The values for all patients are presented in Table 2.
Based on the assumptions described above, the flow momentum equation for direc-
tion z (flow direction) in a cylindrical system becomes:
where; P = P(z, t) is the pressure, Uz = Uz(r, t) is the axial velocity along z axis and 
assuming no flow in direction θ and r.
Womersley’s solution obtained by the analytical integration of Eq. 2 is based on Fou-
rier series in time and Bessel’s function in space. The final equations used to calculate 
blood properties in a Matlab script are therefore as presented below.
The peak velocity, at the centre (r = 0) is given by Fourier series:
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The pressure gradient coefficient Gn can be calculated based on the Eqs.  (3, 4) for a 
peak velocity at r = 0. For any nth harmonic of the Fourier series, one can write:
Therefore,





































Table 2 Comparison of  the flow properties (minimum, mean and  maximum values) 
between CFD and Womersley’s solution
Viscosity μ (Pa s) Flow rate Q (m3/s) WSS τ (Pa) WSSTD dτ/dt (Pa/s)
CFD Womersley CFD Womersley CFD Womersley CFD Womersley
Patient 1
 Min 3.11 × 10−3 3.42 × 10−3 5.64 × 10−8 2.62 × 10−8 −0.42 −0.41 −52.31 −50.10
 Mean 3.42 × 10−3 3.42 × 10−3 8.62 × 10−7 8.14 × 10−7 0.78 0.73 0 0
 Max 9.56 × 10−3 3.42 × 10−3 1.62 × 10−6 1.54 × 10−6 1.51 1.51 75.075 72.22
Patient 2
 Min 2.89 × 10−3 3.09 × 10−3 8.86 × 10−8 7.45 × 10−8 −0.27 −0.28 −63.41 −53.35
 Mean 3.09 × 10−3 3.09 × 10−3 6.08 × 10−7 5.86 × 10−7 1.19 1.15 0 0
 Max 5.12 × 10−3 3.09 × 10−3 1.04 × 10−6 1.00 × 10−6 2.15 2.17 81.50 83.73
Patient 3
 Min 3.62 × 10−3 3.85 × 10−3 9.32 × 10−8 8.62 × 10−8 0.42 0.31 −25.90 −23.53
 Mean 3.85 × 10−3 3.85 × 10−3 3.02 × 10−7 2.92 × 10−7 1.47 1.41 0 0
 Max 4.53 × 10−3 3.85 × 10−3 5.43 × 10−7 5.29 × 10−7 2.58 2.59 51.96 51.88
Patient 4
 Min 3.00 × 10−3 3.11 × 10−3 3.19 × 10−7 3.03 × 10−7 0.73 0.83 −24.91 −25.75
 Mean 3.11 × 10−3 3.11 × 10−3 6.88 × 10−7 6.67 × 10−7 1.89 1.98 0 0
 Max 3.33 × 10−3 3.11 × 10−3 1.20 × 10−6 1.15 × 10−6 3.35 3.43 49.30 48.93
Patient 5
 Min 3.55 × 10−3 3.69 × 10−3 1.52 × 10−7 1.44 × 10−7 0.22 0.14 −81.80 −74.18
 Mean 3.69 × 10−3 3.69 × 10−3 4.89 × 10−7 4.74 × 10−7 1.89 1.82 0 0
 Max 5.31 × 10−3 3.69 × 10−3 7.64 × 10−7 7.46 × 10−7 2.91 2.90 89.56 83.34
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The instantaneous flow rate is given by:
The wall shear stress (WSS) is given by:
For a Newtonian fluid, the wall shear rate γ˙ is linked to the shear stress by:
And the wall shear stress time derivative (WSSTD) is given by:
Although none of the assumptions quoted above are 100% true for blood flows, most 
of them are a fair approximation of reality. Moreover, to assess the effect of the non-
Newtonian character of blood, a CFD computation was performed on COMSOL® Mul-
tiphysics software. These CFD calculations are based on the unsteady Navier–Stokes 
equations that for incompressible and non-Newtonian fluid lead to:
where, f is external volume force, µ is dynamic viscosity that depends on shear rate γ˙ 






In order to describe non-Newtonian behavior of blood a mathematical model is 
needed. As mentioned above, the Carreau model was used to model blood viscosity 
in function of shear rate and in addition in function of  the  hematocrit level based on 
the experimental viscosity measurements [17]. It is four parameters model where these 
















































+ ρ�f momentum equation
Table 3 Carreau model coefficients [17] and  hematocrit levels required for  CFD calcula-
tions
Model Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
μ0 (Pa s) 2.30 × 10−2 2.17 × 10−2 2.77 × 10−2 2.34 × 10−2 2.74 × 10−2
μ∞ (Pa s) 2.73 × 10−3 2.61 × 10−3 3.30 × 10−3 2.77 × 10−3 3.25 × 10−3
λ (s) 1.39 1.48 1.10 1.36 1.12
p (-) 0.39 0.40 0.35 0.39 0.36
Hematocrit (%) 38.0 36.6 42.7 38.4 42.4
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Assuming that vessels are circular a 2D axis symmetric space dimension was used. A 
quadrangle element for mesh was chosen. However, in order to resolve the boundary lay-
ers on solid boundaries an anisotropic boundary layer mesh was added. This type of mesh 
stretches the mesh cells so that the velocity gradient close to the wall is captured. The 
length of the cylindrical domain, representing as simplified vessel, was chosen in order 
to ensure a good compromise between CPU/memory cost and simulation accuracy. The 
length had to be as short as possible to reduce the calculation cost but long enough to 
ensure that the flow will be fully developed. The minimum length required to have a fully 
developed a steady laminar flow could be calculated with a semi-empirical law [21]:
Based on the Eq. (18), the length of the pipe for all examined here diameters was set at 
0.05 m and the measurement point for the comparison of all data was located at 0.025 m. 
The 2D axial symmetry model requires four boundary conditions:
1. A symmetry constraint with an axial symmetry condition at r = 0.
2. An inlet boundary condition with normal inflow velocity. Starting with a mean veloc-
ity equals to half of the peak velocity from the in vivo data, an iterative adjustment is 
performed on that inlet mean velocity in order to fit the unsteady in vivo measured 
peak velocity as follows: 
where, Un+1mean is a new mean velocity for an inlet condition, Unmean is an old mean 
velocity for an inlet condition, Un+1max is a new calculated maximum velocity, Umesmax is a 
measured maximum velocity.
3. An outlet boundary condition with an effective pressure (relative pressure with a ref-
erence pressure level set at 0 Pa.
4. No slip wall condition. 
The iterative steps were repeated until the local maximum velocity of in vivo velocity 
vs. CFD velocity reached relative error a value less than 1%.
Design of the in vitro test bench
The general outline of the test bench is presented in Fig. 4. The circuit starts in an incu-
bator (2, Revco Ultima II RMI3000 Thermo Scientific) where a reservoir (1) filled with a 
medium DMEM (Dulbecco’s Modified Eagle’s Medium) with 1 g Glucose, 25 mM Hepes 
and supplemented with: 10% FBS (Foetal Bovine Serum), 1% l-Glutamine, 1% Penicil-
lin  +  Streptomycin, 2% HAT (Hypoxanthine Aminoptein Thymidine) and 1% NEAA 
(Non-essential amino acid). In order to set the desired viscosity level, a Dextran com-
plex is used. The reservoir is placed in the incubator in order to maintain physiological 
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conditions (pH level at 7.45). This is done by keeping the gas balance at the proper level 
i.e. CO2 5% and air 95%. The mean flow rate is ensured by a centrifugal pump (3, BPX-50 
Biopump Medrotronic) which is specifically designed to pump blood. A one-way valve 
(4, W96029 Clapet Kynar) and a customised piston pump (5, PS01-23  ×  80F-HP-R, 
Linmot) are connected to a linear motor that controls oscillations over the mean flow 
rate. The temperature level (37°C) of the medium is read on the thermocouple (6, PR-
11-2-100-M60-100-E-CLA, Omega). Just before the test section (8), a pressure sensor 
(7, CTE8N01GY0N, Sensortechnics) measures the pressure inside the system. The test 
section is on-line with a microscope (9, DMIL, Leica) connected to a digital camera (10, 
Infinity 2-5C, Lumenera). The camera is able to take pictures of ECs seeded in the test 
section while the system is working. The flow rate is measured by an electromagnetic 
flow meter (11, MM-04-XX-VD-SS-XX-0000-22-1A-1F-00-2R-00-SK, Minimag). The 
last two pieces of equipment inserted in the circuit are solenoid proportional valves (12, 
13, type 2833, Bürkert). All devices are connected by flexible tubing (Tygon B-44-4X, 
Masterflex). To ensure sterility and mobility, the system is enclosed in a polycarbon-
ate transparent box. Temperature of the medium is controlled by a heater incorporated 
in the system (15, Cirrus 40 PTC fan heater, DBK). The whole package is controlled by 
National Instruments real-time CompactRIO® system (NI9024) controller under Lab-
VIEW™ environment. The control strategy is based on the closed loop with Internal 
Model Control and supported PID controllers in order to allow a feedback to all meas-
ured changes of the environment such as temperature, viscosity, flow or pressure.
Fig. 4 The in vitro test bench. The different parts of the in vitro test bench are depicted. 1 reservoir, 2 incuba-
tor, 3 centrifugal pump, 4 one–way valve, 5 custom designed piston pump, 6 thermocouple, 7 pressure sen-
sor, 8 test section, 9 microscope, 10 CCD camera, 11 flow meter, 12, 13 solenoid proportional valves, 14 AC/DC 
controller, 15 heating system, 16 thermocouple, 17 PC class computer/notebook/touch screen computer.
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Control strategy of the in vitro test bench
The principle of the control loop of the flow pulsatile rate is presented in Fig. 5. The ref-
erence signal is divided into two signals: the mean flow and the pulsatile fluctuations of 
the flow. From that division, we have two main controls. In the first control (Centrifugal 
pump in Fig. 5 as a red square), the mean flow is controlled by the PI controller number 
II and the function “mean II”. The function “mean II” is responsible for calculating the 
mean flow at each cycle. It adds every point of the measured flow cycle and divides the 
latter by the number of the measured samples for this cycle. Then the signal is sent as a 
measured signal to the adder in order to compare with the mean reference value. After 
that, the controller PI II sets the rotation of the centrifugal pump in order to get the 
desired mean flow rate [the transfer function GCP(s)]. Thanks to the function “mean II” 
the control loop is less sensitive to disturbances on the mean flow, which helps to achieve 
the stability of the whole system. The second control loop is responsible for controlling 
the shape of the pulsatile flow. This loop is based on the Internal Model Control (Inter-
nal Model Control in Fig. 5 as a blue square) and is additional to the PI controller. Basi-
cally, the reference signal is compared with a measured signal and is sent to the internal 
controller GC(s). After that, the controlled signal goes through a saturation block which 
sets the movement limits of the linear motor. The signal is then sent to the controller of 
the linear motor and drives the movements. Later the flow is read by the electromag-
netic flowmeter that is presented in Fig. 5 as a transfer function between the position of 
the linear motor and flowmeter GP(s) and in addition is read by model process GMP(s) in 
order to predict the position of the linear motor. The signal then passes by a filter F and 
is compared with the actual position of the body. In addition, in order to prevent the lin-
ear motor from drifting, we incorporated an additional loop (Drift of the piston in Fig. 5 
as a green square). This loop calculates a mean position for every cycle separately and 
Fig. 5 The concept of the control system. The main control strategy consists in three parts. The internal 
model control (marked as a blue square) is responsible to control the position of the piston pump. In order 
to reduce noises from measured flow signal as well to avoid drift of the piston a filter (marked F) and an 
additional loop which is based on a proportional-integral controller and a function Mean I were incorporated 
(marked as a green square). To control the mean flow rate a proportional-integral controller and a function 
Mean II were added (marked as a red square).
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compares it with the mean position previously set. If there is any drift, the PI controller 
number II modifies the reference signal of the flow. The purpose of the system is to be 
as close as possible to reality. In the real human body, the condition that keeps the cells 
alive is temperature, which must be kept between 36 and 38°C. From a fluid-mechanics 
point of view the constant temperature helps to maintain certain conditions of the liquid 
such as viscosity. Viscosity is an important variable in the investigated system as it plays 
a role on the response of the system and is used to calculate the shear stress that acts on 
the vascular cells. Therefore, the additional heating system had to be incorporated in 
order to control the temperature of the medium. The heat is controlled by a PTC heater 
with a fan (Fig. 4, marked as 15 and 16). The control strategy is based on the tempera-
ture measured by the liquid thermocouple and the air heater with the fan. Basically, the 
thermocouple measures the apparent temperature of the liquid and compares it with the 
desired one. If there is a difference, the control loop sends a signal to the relay (switch) 
that opens or closes the electrical circuit and directly powers the heater and air inside 
the box is heated.
Results
In order to extract additional physical quantities such as flow, wall shear stress and wall 
shear stress time derivative from in vivo measurements, they had to be post-processed. 
In this work we aimed to compare the two methods to calculate the parameters of inter-
est: CFD calculation and Wormesley’s solution. The results of these comparisons are 
presented in Figs. 6, 7, 8. After the in vivo measurements using the ComboWire® (see 
“Methods”), the velocity profiles inside coronary arteries were calculated (Fig.  6, 1st 
column). The calculated values are shown for time steps 0, 0.2, 0.4, 0.6 and 0.8  s. The 
maximum velocity was set on the basis of in vivo measurements. It is therefore logical 
to detect no difference at the centre r = 0 (Fig. 6, 2nd column). The main observations 
are the following: the relative error increases while velocity decreases. The largest error 
was found for patient 1 (maximum 10%) and the smallest for patient 4 (maximum 3.2%). 
Womersley’s solution underestimates values as compared to CFD. For example, compare 
solid line (CFD calculation) and solid line with bullets (Womersley’s solution) for patient 
1. Velocity profiles become slightly flat in the centre of the arteries compared to typical 
Newtonian solution and it is well presented for patient 1 and 2. In some cases, patients 
present negative values next to the wall at time step 0 s (patient 1 and 2).
The differences in the velocity profiles could be related to the different methodolo-
gies used to calculate the viscosity in the two methods, as in the Womersley’s solution 
an average viscosity was taken, while for CFD calculation the Carreau model was used 
with parameters presented in Table 3 [17]. Calculated viscosities are shown in Fig. 7, 2nd 
column. The main observations are: Cycles begin and end with higher values which can 
show as abrupt peaks (as seen in patient 1 and 2 for example Fig. 7, 2nd column, graphs 1 
and 2 solid lines). The fluctuations over the average viscosity (solid line with bullets) can 
be important (as seen for first patient Fig. 7, 2nd column, graph 1). Furthermore, blood 
viscosity strongly depends on the applied shear rate and varies a lot between shear rate 
0–100 s−1 [12]. The analysis of shear rate level for all patients (Fig. 8, column 1st), shows 
that during a fraction of the pulsatile period the shear rate is in that range i.e. between 
0 and 100  s−1. Even more, the shear rate can also drop under zero value and achieve 
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negative values. These patients display the most variable viscosities and the largest dif-
ferences between the investigated methods (again in patients 1 and 2).
The flow rate is the physical property that set the conditions for system control. 
Therefore we calculated flow rates for all patients as shown in Fig. 7 and 1st column. 
Although the shape of the pulsatile flow rate is similar, the flow rate predicted with CFD 
is higher than the one obtained with the analytical Womersley’s solution. Nevertheless, 
a similar shape of flow pattern was deduced from calculations by both methods: For all 
patients, a similar flow rate peak for the systolic part and a slowly decreasing flow rate 
Fig. 6 Comparison between Womersley’s solution and non-Newtonian 2D axisymmetric CFD simulations: 
velocity profiles and relative errors. In order to validate Newtonian assumption of the Womersly’s solution 
velocity profiles were drawn (1st column) at time steps t = 0 s, 0.2 s, 0.4 s, 0.6 s and 0.8 s (not presented). 
Graphs present two solutions: The local velocity for each method (left part of the graph); The dimension-
less velocity profiles i.e. the local velocity divided by maximum velocity (right part of graph)—solid lines CFD 
simulations, solid lines with bullets Womersley’s solution. The 2nd column presents relative errors between both 
methods for velocity profiles. Rows from up to down present patients from 1 to 5.
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during the diastolic part were observed. We can notice that the flow pattern as well 
as the regularities or irregularities in the flow varies strongly form one patient to the 
other. The higher flow was observed for patient 1 and the lowest for patient 3 (Fig. 7, 1st 
column, graphs 1 and 3). Besides, the second patient presents a very irregular flow rate 
(Fig. 7. 1st column, graph 2). That strong physiological variability is a key and challeng-
ing issue for the control system of an in vitro system that should mimic accurately the 
in vivo behaviour.
Fig. 7 Comparison between Womersley’s solution and non-Newtonian 2D axisymmetric CFD simulations: 
flow rate and viscosities. One of the most important physical properties is flow rate that is presented in the 1st 
column for one period cycle. The 2nd column presents changes of viscosities during one cycle period—solid 
lines CFD simulations based on Carreau model, solid lines with bullets Womersley’s solution based on constant 
viscosity. Rows from up to down present patients from 1 to 5.
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Finally we also calculated physiological properties that we would like investigated 
the most i.e. wall shear stress (WSS) and wall shear stress time derivative (WSSTD), 
as shown in Fig. 8, 2nd and 3rd columns. The differences between the two calculation 
methods are not significant. The curve obtained using analytical solution follows the 
shape of CFD calculations for all patients and achieves almost the same maximum and 
minimum values for WSS as well as for WSSTD. As can be noticed, for patient 1 and 2, 
the velocity profile presents some reverse flow near the wall during a part of the pulsa-
tile cycle (Fig. 6, 1st column). It is well presented for patients 1 and 2 for time step of 
0 s. This is also marked by the fact that the WSS becomes negative (changes direction) 
Fig. 8 Comparison between Womersley’s solution and non-Newtonian 2D axisymmetric CFD simulations: 
wall shear rate, wall shear stress and wall shear stress time derivative. Vascular endothelial cells respond is 
strongly connected to the hemodynamic properties such as wall shear rate (1st column), wall shear stress 
(2nd column) and wall shear stress time derivative (3rd column)—solid lines CFD simulations, solid lines with 
bullets Womersley’s solution. Rows from up to down present patients from 1 to 5. All graphs are drawn for one 
period cycle.
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during these phases. The WSS is the highest for patient 4 and the lowest for patient 1. 
All WSSTD also presents a peak at the beginning and end of the cycle. Between these 
two peaks oscillations can vary from patient to patient there are more oscillations for 
patients 2–4 comparing to patients 1 and 5. Here again, Womersley’s solution slightly 
underestimated values as compared to CFD values. The lowest and highest values can 
be found for patient 5. Table 2 summarizes minimum, mean and maximum values for all 
calculated physical quantities.
To validate the in vitro test bench conception a comparison between post-processed 
in vivo and in vitro measurements was performed. Thus the velocity measured in vivo 
using the combo wire as well as flow rate measured in vitro by the flow meter were pro-
cessed for further analysis. The comparison was based on the same methodology i.e. the 
Womersley’s solution either set as a desired signal or used to calculate desired flow-gen-
erated quantities such as WSS or WSSTD.
At first, we compared the flow rate that constitutes the physical quantity set as 
parameter for controlling the system. The results obtained for five patients are pre-
sented in Fig. 9, right panel and Table 4. To assay the capacity of the system, the signals 
were recorded during a time period of 60  s and then post-processed by decomposing 
the whole signal in cycles (Fig.  9, right panel grey lines). The average signal was then 
calculated by adding individual cycles and set as a reference signal (Fig. 9, right panel 
black line). All further calculations were made based on this average signal. It is worth 
emphasis that the signal can be precisely followed with a reproducibility having vari-
ability below 7% for all investigated patients. The measured flows fitted well the limits 
described hereinabove. Moreover, the achieved flows accurately reproduce the reference 
in vivo signals with a mean relative error below 5% for all investigated signals. However, 
the control strategy still has difficulties to adapt to rapid changes (peaks) of the flow and 
biggest discrepancies were noticed at these points. To visualise differences, the Fourier 
spectral analysis were calculated (Fig. 9, left-hand panel).
Based on the experimental in vitro data as well as in vivo data, two important physi-
ological quantities i.e. wall shear stress (WSS) and wall shear stress time derivative 
(WSSTD) were also derived and compared. They are shown in Fig. 10. The differences 
observed between the in vivo and in vitro averaged data were correlated to the flow val-
ues measured and presented in the previously paragraph. Like for the flow, the main 
shape of the WSS as well as the WSSTD (grey line) generated in vitro matched well the 
reference signal generated from in  vivo data (black line). However, as mentioned for 
the flow results, the calculated physical quantities for in vitro data are mostly underes-
timated compared to calculated in vivo data. Again, periods of rapid changes (peaks) of 
the WSS/WSSTD were associated to the largest calculated discrepancies. Moreover, due 
to the difficulties encountered in mimicking the fast change of the WSS/WSSTD it was 
not possible to reconstruct accurately enough negative values of the WSS/WSSTD.
Discussion
In vivo pulsatile blood velocity data were successfully obtained for five patients using 
a Doppler flow ComboWire® (Volcano Corp.), although there were some difficulties to 
obtain the Doppler flow signal. For example, placing a wire in a suitable position, i.e., as 
centrally as possible in order to get sufficient signal intensity took several minutes, an 
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inconvenience probably related to the difficulty in choosing the best coronary artery/
place to perform an accurate measurement i.e. to measure maximum velocity avoiding 
any artifact and noises. Patients were selected from those needing coronagraphy accord-
ing to the ethical board’s policy, and we were limited to the use of sites where coro-
nagraphy had to be performed. Within these restrictions, our goal was to find healthy 
Fig. 9 Comparison between flow rates calculated by the Womersley’s solution in in vivo blood vessels and 
in the in vitro test bench. The Fourier spectral analysis was calculated in order to assess the differences in 
reproduced frequencies between Womersley’s solution (black line) and ones obtained in vitro (grey line) (left-
hand panel). On that graph the circle point out the fundamental frequency of the heart cycle. The right panel 
is presented flow rate obtained using the in vitro test bench. The solid black line with points presents desired 
signal, the solid grey line presents measured cycle, solid black line presents average of 60 measured cycles. 
Rows from top to bottom show patients from 1 to 5.
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vessels without stenosis and as straight as possible in order to obtain proper measure-
ments. Nevertheless, some measurements had to be performed close to branches or 
curves. These practical problems add to the inherent variability between successive 
human heart beats, perturbed signals due to movements of the patient, etc. Hence, the 
data obtained were often noisy and additional filtering was needed.
After filtering, the five different in vivo signal measurements were analyzed and post-
processed. Results showed that the flow pattern varied widely among patients and con-
firmed the reported variability of pulsatile flow waveforms observed in the arteries (see, 
e.g., Mills et al. [22], McDonald [23]). The differences among patients in the magnitude 
of the velocities as well as in the shape of the curve could be due to intrinsic differences 
between patients and/or measurement positions.
The main goal was to perform experiments with the simplest settings. First in  vitro 
tests involved straight rigid pipes containing a medium with Newtonian properties. 
However, the necessary velocity measurements had to be made with blood, which has 
non-Newtonian behavior. In this study, we extracted detailed information on the physi-
cal flow quantities, such as pulsatile flow, WSS and WSSTD from in vivo measurements 
using the Wormesley’s solution (usually applied to a Newtonian behavior). Our subse-
quently comparison with numerical non-Newtonian, based on the Carreau model, CFD 
calculations indeed validated the Womersley’s solution for five patients tested. The mean 
relative errors for the flow rate vary between 3.2 and 6.3%. As presented, both techniques 
give rise to similar results with a difference growing for smaller flow rates (Figs. 6, 7, 8). 
Table 4 Comparison of the flow properties (minimum, mean and maximum values) as cal-
culated by non Newtonian unsteady CFD simulations and Womersley’s solution
Viscosity μ (Pa s) Flow rate Q (ml/min) WSS τ (Pa) WSSTD dτ/dt (Pa/s)
Womersley Womersley In vitro Womersley In vitro Womersley In vitro
Patient 1
 Min 3.42 × 10−3 85.2 118.2 −0.16 0.22 −22.01 −13.88
 Mean 3.42 × 10−3 197.8 198.4 0.73 0.74 0 0
 Max 3.42 × 10−3 306.5 298.8 1.50 1.50 37.14 25.95
Patient 2
 Min 3.09 × 10−3 177.7 219.6 −0.30 0.37 −64.40 −19.86
 Mean 3.09 × 10−3 310.4 310.9 1.14 1.15 0 0
 Max 3.09 × 10−3 421.5 395.7 2.16 1.88 75.13 36.09
Patient 3
 Min 3.85 × 10−3 186.7 187.1 0.33 0.42 −25.13 −14.05
 Mean 3.85 × 10−3 380.7 380.9 1.41 1.41 0 0
 Max 3.85 × 10−3 521.1 509.6 2.56 2.69 43.75 27.55
Patient 4
 Min 3.11 × 10−3 315.3 307.2 0.77 0.77 −21.09 −13.83
 Mean 3.11 × 10−3 508.6 508.4 1.88 1.88 0 0
 Max 3.11 × 10−3 709.9 674.5 3.27 3.09 45.28 32.04
Patient 5
 Min 3.69 × 10−3 280.6 305.2 0.13 0.71 −84.83 −13.16
 Mean 3.69 × 10−3 488.9 489.7 1.80 1.81 0 0
 Max 3.69 × 10−3 627.8 632.6 2.87 2.89 87.48 28.21
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Thus, the Womersley’s solution is a fast method that can be used to provide satisfy-
ing approximations especially for the higher flow rates where shear rate is higher than 
100  s−1 and where the non-Newtonian behavior becomes negligible. For some cases, 
where more accurate and detailed analysis is required, is should nevertheless be recom-
mended to use CFD techniques.
Fig. 10 Comparison between wall shear stress and wall shear stress time derivative calculated by the Wom-
ersley’s solution in in vivo blood vessels and in the in vitro test bench. Hemodynamic properties, such as the 
wall shear stress (left panel) and wall shear stress time derivative (right panel) were calculated from Womersley 
simulations of in vivo data (solid black lines) and from reproduction by our in vitro test bench (solid grey lines) 
and plotted against time. Rows from top to bottom refer to patients from 1 to 5. All graphs are drawn for one 
period cycle.
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Based on the previous results and the Womersley’s solution, the comparison with 
experimental in vitro data was performed. The results in Table 4 suggest that the con-
cept behind the whole control system is valid. The mean relative error is below 5% for 
all investigated signals. In addition, we have to bear in mind that we are dealing with 
very fast control loops. LabVIEW™ executes one cycle for all the input/output signals 
in a time period of 5 ms (200 Hz). It is much quicker than in most industrial controls 
of mechanical systems. Also, the system is highly non-linear and depends on external 
conditions such as medium composition that can vary a lot depending on supplements 
or serum. Other sources of variability include properties of the equipment such as, for 
example the diaphragm age, external temperature and so on.
The results obtained for all examined patients with the real-time system are satisfac-
tory. However, the system experienced difficulties to follow rapid flow changes. There-
fore, when fast WSS and WSSTD acceleration/deceleration appeared, a large error was 
generated. This results from the foundations behind the WSS calculation method. It 
indeed involves the use of derivatives which amplifies the noise particularly at higher 
frequencies. As the system struggles to reproduce fast changes, the calculated WSS val-
ues between the reference flow and measured flow may therefore display significant dis-
crepancies, reflected in the calculated relative error. The same principle may be applied 
to WSSTD, whose values are function of a second derivative of the flow. Therefore the 
relative error becomes even higher.
As mentioned earlier, several studies have correlated shear stress perturbations with 
EC behavior. Recently, other studies have correlated WSSTD with the development of 
the atherogenic phenotype [8], with for example, WSSTD-induced EC proliferation, 
upregulation of platelet-derived growth factor (PDGF-A) and monocyte chemoattract-
ant protein-1(MCP-1) and enhanced monocyte binding [8]. Investigations have also 
demonstrated effects of WSSTD and temporal gradient in shear on EC remodeling [8, 
24]. However, the WSSTD signal in these studies was deduced as the result of ramp, 
step, sinusoidal or impulse laminar flow. In this paper, we calculated WSSTD (Figs. 8, 
10, right-hand panel) based on real in vivo and in vitro measurements. Clearly WSSTD 
signals are not a simple impulse or ramp. Thus, during one heartbeat, there was a wide 
variety in the signal, with rapid increases and decreases, as well as different magnitudes 
observed in our patients. How this complex signal variety can influence EC remod-
eling and gene expression remains an open question, which needs to be addressed in 
future studies. We can classify signals recorded from the 5 patients into two groups: 
(1) patients 1 and 5 with two WSSTD peaks at the beginning and end of the cycle and 
relatively constant values in-between; and (2) patients 2, 3, 4 with many random peaks 
during the whole cycle. This observation raises several questions: Is there a difference 
between these two groups regarding their influence on EC remodeling? Could one of 
these two groups reflect patients who develop atherosclerosis without any classical risk 
factors, such as smoking, fat diet or hypertension?
An important question relates to which values can be set as trigger or threshold val-
ues to influence EC functions? In a review [8], three conditions were proposed: (1) 
WSSTD = 0 Pa/s as steady condition; (2) WSSTD = 7.1 Pa/s as low condition; and (3) 
WSSTD = 29.3 Pa/s as high condition. When these conditions were applied to our data 
(Fig. 8), close to 90% of the WSSTD for patient 1 were between −7 and 7 Pa/s, 41.9% 
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for patient 2 and about 60% for the other patients. Furthermore, almost 10% of WSSTD 
were in the range of high values for patient 2; this was about two times less than for the 
other patients. However, that high condition i.e. WSSTD about 29.3 Pa/s appears in a 
fraction of time. It seems that they are placed at higher frequencies of the signal. This 
triggers another question: Is it enough to activate ECs function with high frequency and 
high amplitude stimuli? Feaver et al. [25], demonstrated how the frequency spectrum of 
the wall shear stress signal can regulate the inflammation including NF-kB activity. By 
modifying or removing particular frequency harmonics from a carotid wall shear stress 
signal, they analyzed in vitro the response to human endothelial cells. They found that 
the frequency spectrum, specifically the 0th and 1st harmonics, is a significant regulator 
of inflammation. However, is it valid to the whole mechanisms of shear stress mecha-
notransductions? In the future study, in addition to the mentioned signals stimuli, the 
spectrum analysis of the WSS and WSSTD signal to the ECs will be considered.
This short analysis shows that it is difficult to agree on a constant value and that the 
patterns of variability in different patients are considerable. Nevertheless our study in 5 
patients provides a limited set of preliminary data to plan in vitro experiments and cre-
ate a database of patient flow patterns.
The aim of this project was also to provide bioengineers and physicians with a tool that 
will be able to mimic blood flows and later automatically calculate desired flow proper-
ties, such as WSS and WSSTD.
These calculations of the real coronary wall shear stress signals are critical for future 
development. The challenge will now be to reproduce these signals perfectly in this 
in vitro system. Meeting this challenge (see above) will also allow two critical observa-
tions made in this paper to be exploited: patients can be divided into different groups 
with different behaviors, which are much more complex than described in previous 
publications. These observations in turn raise two critical questions: Which of these 
behaviors is important in triggering the EC pro-atherogenic genes? Do these different 
behaviors explain why many patients with no risk factors develop a clinical condition 
and some patients with risk factors do not?
Conclusions
The presented post-processing method is compatible with any in vivo signals and dem-
onstrated the heterogeneity among patients in the pulsatile pattern in coronary arteries. 
In addition, we provide a new test bench able to reproduce human coronary blood flow 
for in vitro experiments.
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Womersley’s number; Δ: period (s); γ˙ : shear rate (s−1); µ0: dynamic viscosity at zero shear rate (Pa s); µ∞: dynamic viscos-
ity at infinite shear rate (Pa s); λ: relaxation time parameter (s); ζ : dimensionless number; µ: dynamic apparent viscosity 
(Pa s); τ: shear stress (Pa); ω: pulsation (rad/s); ρ: density (kg/m3).
Page 25 of 26Chodzyński et al. BioMed Eng OnLine  (2015) 14:77 
Authors’ contributions
Design of the study: KJC, KZB, GC; data acquisition: KJC, JL, AL, DRS; data analysis: all authors; drafting the manuscript: 
KCJ, KZB, GC. All authors read and approved the final manuscript.
Author details
1 Laboratoire de Médecine Expérimentale (ULB 222 Unit), Route de Gozée 706, 6110 Montigny-Le-Tilleul, Belgium. 2 Fac-
ulté Polytechnique de Mons, Service Fluides-Machines, Université de Mons, 53, rue du Joncquois, 7000 Mons, Belgium. 
3 Service of Cardiology, CHU Charleroi, Boulevard Zoé Drion 1, 6000 Charleroi, Belgium. 4 Laboratory of Molecular Parasi-
tology, IBMM, Université Libre de Bruxelles (ULB), 12 rue des Prof. Jeener et. Brachet, 6041, Gosselies, Belgium. 5 Automatic 
Control Department, University of Mons, 31, Boulevard Dolez, 7000 Mons, Belgium. 6 CREATIS, CNRS UMR 5220, INSERM 
U1044, UCB Lyon1, INSA Lyon, University of Lyon, 7 Av. Jean Capelle Building Blaise Pascal, 69621 Villeurbanne Cedex, 
France. 
Acknowledgments
This project was supported by Gorazdze Cement, member of the Heidelberg Cement Group; we would like to especially 
acknowledge the help of Mr Daniel Gauthier. We also tanks Luc Vanhamme, the Director of Research at the Belgian 
National fund for scientific research. The project was also supported by the CHU Charleroi Scientific Committee. This 
research was partially supported by the EU, 7th FP under Grant Agreement No 269966–Thrombus, Foundation for 
Cardiac Surgery (Brussels, Belgium).
Compliance with ethical guidelines
Competing interests
The authors declare that the research was conducted in the absence of any commercial or financial relationships that 
could be construed as a potential conflict of interest.
Received: 5 February 2015   Accepted: 24 June 2015
References
 1. Libby P, Ridker PM, Hansson GK. Leducq Transatlantic Network on Atherothrombosis: inflammation in atherosclero-
sis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54:2129–38.
 2. Bierman EL. George LYMAN Duff Memorial Lecture atherogenesis in diabetes. Arterioscler Thromb. 1992;12:647–56.
 3. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart 
disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological 
context. Lancet. 1990;335:827–38.
 4. Loscalzo J, Creager MA, Dzau VJ (Eds): Vascular medicine: a textbook of vascular biology and diseases. 2 Sub edition. 
Boston: Lippincott Williams and Wilkins; 1996.
 5. Schwenke DC, St Clair RW. Influx, efflux, and accumulation of LDL in normal arterial areas and atherosclerotic lesions 
of white Carneau pigeons with naturally occurring and cholesterol-aggravated aortic atherosclerosis. Arterioscler 
Thromb. 1993;13:1368–81.
 6. Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Car-
diovasc Med. 2009;6:16–26.
 7. Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest. 2004;85:9–23.
 8. Hsiai TK, Cho SK, Honda HM, Hama S, Navab M, Demer LL, Ho C-M. Endothelial cell dynamics under pulsating flows: 
significance of high versus low shear stress slew rates (d(tau)/dt). Ann Biomed Eng. 2002;30:646–56.
 9. Traub O, Berk BC. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. 
Arterioscler Thromb Vasc Biol. 1998;18:677–85.
 10. Stoner L, McCully KK. Velocity acceleration as a determinant of flow-mediated dilation. Ultrasound Med Biol. 
2012;38:580–92.
 11. Davies PF, Spaan JA, Krams R. Shear stress biology of the endothelium. Ann Biomed Eng. 2005;33:1714–8.
 12. Fung YC. Biomechanics: Circulation. Soft cover reprint of the original 2nd ed. 1997 edition. New York: Springer; 2013.
 13. Benbrahim A, L’Italien GJ, Milinazzo BB, Warnock DF, Dhara S, Gertler JP, et al. A compliant tubular device to study the 
influences of wall strain and fluid shear stress on cells of the vascular wall. J Vasc Surg. 1994;20:184–94.
 14. Peng X, Recchia FA, Byrne BJ, Wittstein IS, Ziegelstein RC, Kass DA. In vitro system to study realistic pulsatile flow and 
stretch signaling in cultured vascular cells. Am J Physiol Cell Physiol. 2000;279:C797–805.
 15. Malek AM, Ahlquist R, Gibbons GH, Dzau VJ, Izumo S. A cone-plate apparatus for the in vitro biochemical and 
molecular analysis of the effect of shear stress on adherent cells. Methods Cell Sci. 1995;17:165–76.
 16. Labadie RF, Antaki JF, Williams JL, Katyal S, Ligush J, Watkins SC, et al. Pulsatile perfusion system for ex vivo investiga-
tion of biochemical pathways in intact vascular tissue. Am J Physiol. 1996;270(2 Pt 2):H760–8.
 17. Chodzynski KJ: In vitro facilities for testing vascular tissues submitted to physiological pulsatile flow conditions. PhD 
thesis, University of Mons; 2013.
 18. Womersley JR. Method for the calculation of velocity, rate of flow and viscous drag in arteries when the pressure 
gradient is known. J Physiol. 1955;127:553–63.
 19. Zamir M, Ritman EL. The physics of pulsatile flow. 2000th ed. New York: Springer; 2000.
 20. Fung YC. Biomechanics: mechanical properties of living tissues, Second Edition. 2nd ed. New York: Springer; 1993.
 21. Coussement G. Techniques numériques en mécanique des fluides. Faculté Polytechnique, UMONS; 2011.
 22. Mills CJ, Gabe IT, Gault JH, Mason DT, Ross J, Braunwald E, et al. Pressure-flow relationships and vascular impedance 
in man. Cardiovasc Res. 1970;4:405–17.
Page 26 of 26Chodzyński et al. BioMed Eng OnLine  (2015) 14:77 
 23. Taylor DEM. Blood flow in arteries. 2nd ed. By D. A. McDonald. Edward Arnold, London, 1974. Pp. xviii+496. £12. Q J 
Exp Physiol Cogn Med Sci. 1974;60:65.
 24. Bao X, Lu C, Frangos JA. Temporal gradient in shear but not steady shear stress induces PDGF-A and MCP-1 expres-
sion in endothelial cells: role of NO, NF kappa B, and egr-1. Arterioscler Thromb Vasc Biol. 1999;19:996–1003.
 25. Feaver RE, Gelfand BD, Blackman BR. Human haemodynamic frequency harmonics regulate the inflammatory 
phenotype of vascular endothelial cells. Nat Commun. 2013;4:1525.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
